The Royal Brisbane and Women's Hospital is a tertiary hospital located in Herston, a suburb of Brisbane, Queensland, Australia. It is operated by Queensland Health, a department of the Queensland Government.

There are 929 beds in Royal Brisbane & Women's Hospital-Endocrinology.

During the past decade, Royal Brisbane & Women's Hospital-Endocrinology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Brisbane & Women's Hospital-Endocrinology" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Royal Brisbane & Women's Hospital-Endocrinology" are "Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes" (2 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Royal Brisbane & Women's Hospital-Endocrinology" in a lesser frequency.

Most popular intervention types in "Royal Brisbane & Women's Hospital-Endocrinology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "DIO-902" (2 trials), "linagliptin" (2 trials), "DIO-902 placebo" (1 trials), "Empagliflozin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Brisbane & Women's Hospital-Endocrinology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Royal Brisbane & Women's Hospital-Endocrinology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Royal Brisbane & Women's Hospital-Endocrinology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Brisbane & Women's Hospital-Endocrinology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".